藻酸双脂钠(polysaccharide sulfate简称PSS)系一种防治缺血性心脑血管病的新药。临床证明,本品治疗脑梗塞显效率为65.2%,总有效率为92.3%。不良反应仅见个案报告。现将我科1985年2月-1988年5月应用该药治疗715例,发生不良反应7例(占0.98%),分析如下。 临床资料 7例均为缺血性脑血管病,诊断符合1978年第二届全国神经精神科学会议 Sodium alginate (polysaccharide sulfate referred to as PSS) is a new drug for the prevention and treatment of ischemic cardiovascular disease. Clinical evidence, the FDA effective treatment of cerebral infarction was 65.2%, the total effective rate was 92.3%. Adverse reactions only see the case report. Now our department February 1985 - May 1988 application of the drug treatment of 715 cases, 7 cases of adverse reactions (accounting for 0.98%), the analysis is as follows. Seven cases of clinical data were ischemic cerebrovascular disease, diagnosis in line with the Second National Neuropsychiatric Conference in 1978